Last updated: September 3, 2023
Sponsor: Peking Union Medical College Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neoplasms
Genitourinary Cancer
Treatment
99mTc-CNDG SPECT/CT
Clinical Study ID
NCT06030817
K1999
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18-70 years old
- Patients diagnosed with malignant glioma, colorectal cancer, pancreatic cancer, lungcancer, breast cancer, or other malignant tumors through imaging techniques such asMRI, CT, and ultrasound, and who are scheduled for surgical resection or biopsy
- Solid tumor sizes greater than 2cm
- Voluntarily agree to participate and sign an informed consent form
- Can provide complete surgical records, pathological results, control data, andclinical follow-up results
Exclusion
Exclusion Criteria:
- Pre-treatment such as chemotherapy and targeted therapy has been administered
- Pregnancy and breastfeeding
- Claustrophobia
- The condition is severe and difficult to cooperate with
- Unable to obtain relevant control imaging data and clinical information
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: 99mTc-CNDG SPECT/CT
Phase:
Study Start date:
August 11, 2023
Estimated Completion Date:
December 31, 2025
Connect with a study center
Peking Union Medical College Hospital
Beijing, Beijing 100730
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.